Steve Weinrauch Sells 6,674 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the transaction, the executive vice president directly owned 78,062 shares in the company, valued at approximately $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Trupanion Stock Up 0.5%

Shares of TRUP traded up $0.12 during midday trading on Tuesday, hitting $22.17. 278,529 shares of the company’s stock traded hands, compared to its average volume of 372,582. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock has a market capitalization of $967.06 million, a price-to-earnings ratio of 37.58 and a beta of 1.45. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The firm’s fifty day moving average is $24.39 and its 200-day moving average is $29.50.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the company posted ($0.03) EPS. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Institutional Trading of Trupanion

Several institutional investors and hedge funds have recently bought and sold shares of the business. Federated Hermes Inc. purchased a new stake in shares of Trupanion in the 3rd quarter valued at $33,000. Kelleher Financial Advisors purchased a new position in shares of Trupanion during the third quarter worth $74,000. Kemnay Advisory Services Inc. acquired a new position in Trupanion during the fourth quarter valued at $64,000. Parallel Advisors LLC lifted its position in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Finally, PNC Financial Services Group Inc. boosted its holdings in Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares during the last quarter.

Analysts Set New Price Targets

A number of analysts recently commented on TRUP shares. Piper Sandler lowered their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Stifel Nicolaus dropped their price objective on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Bank of America cut their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Finally, Cantor Fitzgerald lowered their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $42.25.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.